A Bloomington developer is creating a new neighborhood on the city’s far east side. Here are the details. Where is the new Bloomington neighborhood? At 4415 E. Moores Pike, a bit west of the ...

Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...

Threat actors are using AI to supercharge tried-and-tested TTPs. When attacks move this fast, cyber-defenders need to rethink their own strategy. Fraudsters often target the accounts of the deceased ...